Population-based case-control study of oral ketoconazole treatment for birth outcomes

Congenital Anomalies

Volumn 45, Issue 1, 2005, Pages 5-8

  Kazy, Zoltán ^a   Puhó, Erzsébet ^a   Czeizel, Andrew E ^a,b  

^a FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

^b NONE   (Hungary)

Author keywords

Case control study; Congenital abnormalities; Ketoconazole; Preterm birth; Teratogenic effect

Indexed keywords

KETOCONAZOLE; ANTIFUNGAL AGENT;

ARTICLE; BIRTH WEIGHT; CONGENITAL MALFORMATION; CONTROLLED STUDY; DERMATOMYCOSIS; DISEASE PREDISPOSITION; FETUS DEVELOPMENT; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MATERNAL CARE; NEWBORN CARE; PREGNANCY; PRIORITY JOURNAL; TERATOGENICITY; VAGINA CANDIDIASIS; ADULT; CASE CONTROL STUDY; DRUG EFFECT; EPIDEMIOLOGY; FEMALE; HUNGARY; MALE; NEWBORN; ORAL DRUG ADMINISTRATION; PREGNANCY OUTCOME; PREMATURITY;

ABNORMALITIES, DRUG-INDUCED; ADMINISTRATION, ORAL; ADULT; ANTIFUNGAL AGENTS; BIRTH WEIGHT; CASE-CONTROL STUDIES; EPIDEMIOLOGIC STUDIES; FEMALE; FETAL DEVELOPMENT; GESTATIONAL AGE; HUMANS; HUNGARY; INFANT, NEWBORN; INFANT, PREMATURE; KETOCONAZOLE; MALE; PREGNANCY; PREGNANCY OUTCOME;

EID: 21344469679     PISSN: 09143505     EISSN: 17414520     Source Type: Journal    
DOI: 10.1111/j.1741-4520.2005.00053.x     Document Type: Article

References (15)

1. Amado JA, Pesquara C, Gonzales EM et al. (1990) Successful treatment with ketoconazole of Cushing's syndrome in pregnancy. Postgrad Med J 66: 221-223.
2. Briggs GG, Freeman RK, Yaffe SJ (1998) Drugs in Pregnancy and Lactation, 5th edn. Williams & Wilkins, Baltimore.
3. Buttar HS, Moffatt JH, Bura C (1989) Pregnancy outcome of ketoconazole treated rats and mice. Teratology 34: 444.
4. Czeizel AE (1997) The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 55: 299-305.
5. Czeizel AE, Rockenbauer M, Siffel Cs, Varga E (2001) Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996. Teratology 63: 176-185.
6. Czeizel AE, Petik D, Vargha P (2003) Validation studies of drug exposures in pregnant women. Pharmacoepidemiol Drug Saf 12: 409-416.
7. Food and Drug Administration (1980) Fetal risk summary. Federal Register 44: 37434-37467.
8. Friedman JM, Polifka JE (1996) The Effect of Drugs on the Fetus and Nursing Infant. Johns Hopins University Press, Baltimore.
9. Lind J (1985) Limb malformation in a case of hydrops fetalis with ketoconazole use during pregnancy (Abstract). Arch Gynecol 237 (Suppl.): 398.
10. Luscher KP, Schneitter J, Vogt HP (1987) Frequency of candidiasis during pregnancy and therapy with ketoconazole-ovula. Schweiz Rundsch Med Prax 76: 1285-1289.
11. Nishikawa S, Hara T, Muyazaki H, Ohguro Y (1984) Reproduction studies of KW-144 in rats and rabbits. Kiso To Rinsho (Clin Rep) 18: 1433-1448.
12. Roberts RB (1986) Infectious Diseases. Pathogenesis, Diagnosis and Therapy. Year Book Medical Publishers, Chicago.
13. Rosa F (1993) Personal communication. In: Briggs GG, Freeman RK, Yaffe SJ (1998) Drugs in Pregnancy and Lactation, 5th edn. Williams & Wilkins, Baltimore, p. 580.
14. Rosa F (1993) Personal communication. In: Briggs GG, Freeman RK, Yaffe SJ (1998) Drugs in Pregnancy and Lactation, 5th edn. Williams & Wilkins, Baltimore, p. 580.
15. Shepard TH (1998) Catalog of Teratogenic Agents, 8th edn. Johns Hopkins University Press, Baltimore.